Company / SG&A per Share
NEKTAR THERAPEUTICS SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$5.54
FY2025
5-year range
$0.40 / $5.54
FY2021-FY2025
Trend
+1270.8%
vs FY2024
Sector context
#28 of 210
Health Care
What the data says
SG&A per Share changed +1271% YoY in FY2025, a notable deviation from the 9-year average annual change of +149%.
Based on SEC 10-K filings.
5.54 in FY2025 with a 5-year CAGR of +64.4%. Top quartile in the Health Care sector.
Increased from $0.65 to $5.54 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +123.3%
- 5-Year CAGR
- +64.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 210This company $5.54 Sector average $29.50
▼
-81.2% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 1270.8% year-over-year.
- Ranks #28 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.54 | +1270.8% |
| FY2024 | $0.40 | -37.9% |
| FY2023 | $0.65 | +30.9% |
| FY2022 | $0.50 | -27.0% |
| FY2021 | $0.68 | +47.8% |
| FY2020 | $0.46 | +52.9% |
| FY2019 | $0.30 | +8.7% |
| FY2018 | $0.28 | -18.8% |
| FY2017 | $0.34 | +13.0% |
| FY2016 | $0.30 | -8.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026